Mankind Pharma Limited Max Pain Analysis
What is Max Pain?
Max Pain theory states the underlying gravitates toward the strike where option writers face minimum collective loss at expiry. For MANKIND, that strike is ₹2,400. Spot at ₹2,327.9 is 3.0% below max pain — possible upward gravitational pull into expiry.
Max Pain Level
The current max‑pain strike for Mankind Pharma Limited (MANKIND) is ₹2,400. Max pain is the strike at which the aggregate loss of options writers (call and put writers) would be minimized, often acting as a magnetic point that the underlying price gravitates toward as expiration approaches.
Spot vs Max Pain Gap
The spot price of ₹2,327.9 sits about 3 % below the max‑pain level, indicating a modest upside bias for the underlying to move toward the ₹2,400 strike. This gap suggests that, all else equal, market participants may experience a pull‑back in the spot price as the expiration date nears.
Shift Signal
The max‑pain indicator shows no shift versus yesterday, implying that the collective positioning of options writers has remained stable over the last trading session. A static max‑pain figure typically means that the existing open‑interest distribution is still anchoring the expected price movement near the same strike.
Expiry Context
Max pain is derived from the net open interest of all outstanding call and put contracts; the strike with the smallest combined writer loss becomes the “pain” point. In the final week before expiry, it is common for the underlying price to oscillate around this level, as market makers hedge and unwind positions. However, this is a statistical tendency—not a guarantee—that the spot will settle precisely at the max‑pain strike.
Data Note
The spot is ₹2,327.9, roughly ₹72.1 below the max‑pain strike, with 25 days remaining until the September 29 expiration.
Data as of 2026-09-04